[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100586591":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":14,"responsibleParty":77,"collaborators":7,"id":79,"slug":80,"hasResults":81,"nctId":82,"briefTitle":83,"officialTitle":83,"acronym":84,"eligibilityCriteria":85,"healthyVolunteers":81,"sex":86,"minAge":87,"maxAge":7,"enrollmentInfo":88,"targetDuration":7,"studyType":91,"phases":7,"briefSummary":92,"conditions":93,"keywords":7,"overallStatus":17,"whyStopped":7,"lastUpdateSubmitDate":95,"lastUpdatePostDateStruct":96,"startDateStruct":99,"completionDateStruct":101,"leadSponsor":103,"locationsCount":104},{"fullName":5,"class":6},"Societe dEtude, de Recherche et de Fabrication","INDUSTRY",null,[9],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Clinical department","CONTACT","+33472056010","clinical@serf.fr",[15,31,42,51,66],{"facility":16,"status":17,"city":18,"state":7,"zip":7,"country":19,"countryCode":20,"cosmosGeoPoint":21,"geoPoint":26,"contacts":27},"CHU Dijon","RECRUITING","Dijon","France","FR",{"type":22,"coordinates":23},"Point",[24,25],5.01391,47.31344,{"lat":25,"lon":24},[28],{"name":29,"role":11,"phone":12,"phoneExt":7,"email":30},"Pr Baulot","clinical_serf@stryker.com",{"facility":32,"status":17,"city":33,"state":7,"zip":7,"country":19,"countryCode":20,"cosmosGeoPoint":34,"geoPoint":38,"contacts":39},"HCL Croix-Rousse","Lyon",{"type":22,"coordinates":35},[36,37],4.84789,45.74906,{"lat":37,"lon":36},[40],{"name":41,"role":11,"phone":12,"phoneExt":7,"email":30},"Pr Lustig",{"facility":43,"status":44,"city":33,"state":7,"zip":7,"country":19,"countryCode":20,"cosmosGeoPoint":45,"geoPoint":47,"contacts":48},"HCL Lyon Sud","NOT_YET_RECRUITING",{"type":22,"coordinates":46},[36,37],{"lat":37,"lon":36},[49],{"name":50,"role":11,"phone":12,"phoneExt":7,"email":30},"Pr Fessy",{"facility":52,"status":17,"city":53,"state":7,"zip":7,"country":19,"countryCode":20,"cosmosGeoPoint":54,"geoPoint":58,"contacts":59},"CHU Saint Etienne","Saint-Etienne",{"type":22,"coordinates":55},[56,57],4.39,45.43389,{"lat":57,"lon":56},[60,62,65],{"name":61,"role":11,"phone":12,"phoneExt":7,"email":30},"Pr Philippot",{"name":63,"role":64,"phone":7,"phoneExt":7,"email":7},"Pr Farizon","PRINCIPAL_INVESTIGATOR",{"name":61,"role":64,"phone":7,"phoneExt":7,"email":7},{"facility":67,"status":17,"city":68,"state":7,"zip":7,"country":19,"countryCode":20,"cosmosGeoPoint":69,"geoPoint":73,"contacts":74},"CHU Strasbourg","Strasbourg",{"type":22,"coordinates":70},[71,72],7.74553,48.58392,{"lat":72,"lon":71},[75],{"name":76,"role":11,"phone":12,"phoneExt":7,"email":30},"Pr Bonnomet",{"type":78,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100586591","clinical-performance-of-xpeo-e-liner-in-serf-dual-mobility-cups-100586591",false,"NCT06917365","Clinical Performance of XPEO-E Liner in SERF Dual-mobility Cups","2024-01-XPEO-E","Inclusion Criteria:\n\n* Male or female adults.\n* Patient that needs to be implanted with a SERF total hip prosthesis.\n* Patient responding to IFU requirement.\n* Patient affiliated to French social security.\n* Patient who has provided a dated and signed informed consent form.\n\nExclusion Criteria:\n\n* Patient protected by a French legal measure (under legal protection, guardianship or curatorship).\n* Patient unable of expressing consent, according to the investigator.\n* Patient deprived of liberty or hospitalized against his consent.\n* Pregnant or breastfeeding patient.\n* Patient presenting a contraindication to the implantation of medical devices according to the instructions for use.\n* Patient with a contraindication to radiographic follow-up.\n* Patient not being, a priori, capable of respecting the schedule of follow-up visits, according to the investigator.\n* Patient unable to complete a self-questionnaire, according to the investigator.","ALL","18 Years",{"count":89,"type":90},500,"ESTIMATED","OBSERVATIONAL","XPEO-E liner is CE marked under MDD 93\u002F42\u002FCEE by equivalency with CI E liner. No pertaining data on XPEO-E liner is yet available. However, clinical evaluation concludes on a reaching of performance and safety and compliance with essential requirements. This study intends to collect data on XPEO-E in order to allow a transit to MDR 2017\u002F745 (EU).\n\nXPEO-E liner is intended to be used with NOVAE cups and SERF femoral heads and Stems. XPEO-E liner will be used according to their CE marking. These devices are intended for hip replacements with the aim of improving quality of life and reducing pain by replacing a damaged joint.\n\nThe follow-up visits are established according to the current practice. Additional procedure will only consist on questionnaires that will be filled by the patient and\u002For the surgeons.",[94],"Total Hip Arthroplasty (THA)","2026-04-09",{"date":97,"type":98},"2026-04-13","ACTUAL",{"date":100,"type":98},"2025-10-27",{"date":102,"type":90},"2032-03-31",{"name":5,"class":6},5]